Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies.
Ratings
4.1 / 5
7 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Helen I. Torley, MB.Ch.B.$7.2B
Market Cap • 26/07/20241998
(há 26 anos)
2004
(20 years ago)
NASDAQ
Listagem
San Diego
Sede • California393
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
HALOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.